Mentor B9604 Syringe Recall (Z-2614-2026)
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Mentor Texas LP is recalling 1,401 expired BD 302995 syringes distributed to CA, FL, and PA due to a distribution system failure.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 7, 2026 and geographically references California, Florida, Pennsylvania. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, devices.
What Happened
Mentor Texas LP recalled a single lot of expired syringes that were distributed due to a distribution system control failure.
Which Products Are Affected
The recall involves SYRINGE LUER LOK 10CC-200/BOX with BD Product Code: 302995 and Mentor Product Code: B9604. A total of 1,401 syringes from Lot Number: 8298877 (UDI-DI/GTIN: 30382903029952) were affected. Distribution was limited to California, Florida, and Pennsylvania.
What You Should Do
Consumers should contact Mentor Texas LP regarding the recalled syringes. The recall was initiated voluntarily by the firm via letter on April 28, 2026.
Why This Matters
The Class II recall affects 1,401 syringes distributed in three states after expiration due to a control failure.
Source
FDA recall number Z-2614-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (800 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 7, 2026.
Frequently Asked Questions
Common questions about this FDA recall.